Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

LON/0RHR stock hub

LON/0RHR has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0RHRis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

744M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0RHR

In the news

Latest news · LON/0RHR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E79.5

P25 12.9P50 16.9P75 23.5

Trailing P/E392.5

P25 15.9P50 22.9P75 35.8

ROE3.3

P25 -54.2P50 2.1P75 13.7

ROIC6.6

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0RHR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

196

Groups with data

Currency

USD

Showing 196 of 196 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	UK
Employees	178
Employees Change	56%
Employees Change Percent	45.9
Enterprise value	CHF 730.2M
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	CH0325814116
Last refreshed	2026-05-10
Market cap	CHF 744M
Price	CHF 20.22
Price currency	CHF
Rev Per Employee	609,669.07x
Sector	Healthcare
Sic	2836
Symbol	lon/0RHR
Website	https://kurosbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.25%
EV Earnings	385.25x
EV/EBIT	109.02x
EV/EBITDA	79.27x
EV/FCF	-339.59x
EV/Sales	6.68x
FCF yield	-0.29%
Forward P/E	79.5x
P/B ratio	11.85x
P/E ratio	392.51x
P/S ratio	6.86x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.13%
EBITDA Margin	7.89%
Gross margin	87.26%
Gross Profit	CHF 94.7M
Gross Profit Growth	16.97%
Gross Profit Growth Q	62.08%
Gross Profit Growth3 Y	45.34%
Gross Profit Growth5 Y	47.39%
Net Income	CHF 1.9M
Net Income Growth Quarters	1%
Net Income Growth Years	3%
Pretax Margin	3.43%
Profit Margin	1.75%
Profit Per Employee	CHF 10,648
Profitable Years	1
ROA	4.94
Roa5y	-2.41
ROCE	9.76
ROE	3.31
Roe5y	-9.76
ROIC	6.65
Roic5y	-7.91

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-17.36%
Cagr3y	150.84%
Cagr5y	57.9%
EPS Growth Quarters	1
EPS Growth Years	3
FCF Growth Q	-74.46%
OCF Growth Q	-42.98%
Revenue Growth	71.51x
Revenue Growth Q	66.91x
Revenue Growth Quarters	14x
Revenue Growth Years	8x
Revenue Growth3 Y	44.99x
Revenue Growth5 Y	47.32x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CHF 1.29
Assets	CHF 99.5M
Cash	CHF 14.7M
Current Assets	CHF 60.6M
Current Liabilities	CHF 30.9M
Debt	CHF 1M
Debt EBITDA	CHF 0.11
Debt Equity	CHF 0.02
Debt FCF	CHF -0.48
Equity	CHF 62.8M
Interest Coverage	24.38
Liabilities	CHF 36.7M
Long Term Assets	CHF 38.8M
Long Term Liabilities	CHF 5.8M
Net Cash	CHF 13.7M
Net Cash By Market Cap	CHF 1.84
Net Cash Growth	3.28%
Net Debt EBITDA	CHF -1.6
Net Debt Equity	CHF -0.22
Tangible Book Value	CHF 32.4M
Tangible Book Value Per Share	CHF 0.83
WACC	8.57

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.96
Inventory Turnover	1.17
Net Working Capital	CHF 15.9M
Quick ratio	1.42
Working Capital	CHF 30.1M
Working Capital Turnover	CHF 3.25

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-11.26%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-17.35%
200-day SMA	26.53
3Y total return	1,479.35%
50-day SMA	23.92
50-day SMA vs 200-day SMA	50under200
5Y total return	881.34%
All Time High	34.08
All Time High Change	-40.69%
All Time High Date	2025-10-20
All Time Low	1.28
All Time Low Change	1,479.35%
All Time Low Date	2023-03-16
ATR	0.94
Beta	0.79
Ch YTD	-26.5
High	20.34
High52	34.08
High52 Date	2025-10-20
High52ch	-40.69%
Low	20.1
Low52	19.11
Low52 Date	2026-05-04
Low52ch	5.79%
Ma50ch	-15.49%
Price vs 200-day SMA	-23.79%
RSI	33.67
RSI Monthly	47.68
RSI Weekly	37
Sharpe ratio	-0.44x
Sortino ratio	-0.53
Total Return	-11.26%
Tr YTD	-26.5
Tr1m	-11.95%
Tr1w	1.51%
Tr3m	-20.35%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CHF 6.6M
Operating Income Growth	130.5
Operating Income Growth Q	1,392.1
Operating margin	6.13

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	28,885,878%
Net Borrowing	-569,940.4
Shares Insiders	26.27%
Shares Institutions	16.79%
Shares Qo Q	5.6%
Shares Yo Y	11.26%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CHF -5.3M
Average Volume	26,332.45x
Bv Per Share	1.6
CAPEX	CHF -1.8M
Ch1m	-11.95
Ch1w	1.51
Ch1y	-17.35
Ch3m	-20.35
Ch3y	1,479.3
Ch5y	881.3
Ch6m	-25.95
Change	-1.43%
Change From Open	-0.46
Close	20.51
Days Gap	-0.98
Depreciation Amortization	1,885,864.5
Dollar Volume	73,140.1
Earnings Date	2026-08-13
EBIT	CHF 6.6M
EBITDA	CHF 8.6M
EPS	CHF 0.05
F Score	3
FCF	CHF -2.2M
FCF EV Yield	-0.29x
Financing CF	1,046,144
Fiscal Year End	December
Founded	2,016
Goodwill	17,821,456.1
Graham Number	1.4059
Graham Upside	-93.05
Income Tax	CHF 1.9M
Investing CF	-1,812,177
Is Primary Listing	0
Last Earnings Date	2026-03-10
Last Report Date	2025-12-31
Ma150	26.66
Ma150ch	-24.18%
Ma20	22.57
Ma20ch	-10.41%
Net CF	5,201
Next Earnings Date	2026-08-13
Open	20.31
Position In Range	48.18
Ppne	3,432,112
Price Date	2026-05-08
Price EBITDA	CHF 86.92
Ptbv Ratio	22.97
Relative Volume	0.14x
Revenue	108,521,094x
SBC By Revenue	2.88x
Share Based Comp	3,123,572
Tax By Revenue	1.75x
Tax Rate	50.91%
Tr6m	-25.95%
Volume	3,618
Z Score	15.61

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0RHR pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0RHR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0RHR?

Insider, institutional, and short-interest positioning.

Institutional ownership

+16.8%

Share of float held by funds and institutions

Insider ownership

+26.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+11.3%

Negative means the company is buying back shares.

Technical

LON/0RHR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

33.7

Neutral momentum band

Price vs 200-day MA

-23.8%

50/200-day relationship not available

Beta (5Y)

0.79

Less volatile than the market

Sharpe ratio

-0.44

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0RHR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0RHR stock rating?

lon/0RHR is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0RHR analysis?

The full report lives at /stocks/lon/0RHR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0RHR?

The latest report frames lon/0RHR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0RHR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.